← Research library

GHRP-2 (Pralmorelin)

Growth hormone axis · By Preptide Pro editorial team · Last updated

GHRP-2 (Pralmorelin) is a growth hormone axis peptide, and it is not FDA-approved. A synthetic ghrelin-receptor agonist. It is approved in Japan as a diagnostic agent for growth hormone deficiency.

Not FDA-approved

Chemistry (PubChem)

PubChem CID6918245
CAS number158861-67-7
Molecular formulaC45H55N9O6
Molecular weight818 g/mol
Other namesPralmorelin, GHRP-2, KP-102, pralmorelina, pralmoreline, KP 102, Ala-beta-Nal-Ala-Trp-Phe-Lys-NH2, pralmorelinum

Is GHRP-2 (Pralmorelin) FDA-approved?

Not FDA-approved. No matching NDA or BLA was found in openFDA (Drugs@FDA).

How much research is there on GHRP-2 (Pralmorelin)?

PubMed lists 258 records for “GHRP-2 OR pralmorelin”, of which 58 are tagged as human clinical trials.

Most recent PubMed records
Recent studyJournalDate
Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review.Sex Med Rev2026 Sep 30
Differentiating hypothalamic from pituitary adrenal insufficiency: underlying causes and diagnostic utility of the corticotropin-releasing hormone and growth hormone-releasing peptide-2 stimulation tests.Endocr J2026 Sep 11
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.Front Endocrinol (Lausanne)2026
Possible Involvement of Hypothalamic Dysfunction in Long COVID Patients Characterized by Delayed Response to Gonadotropin-Releasing Hormone.Int J Mol Sci2026 Jan 14
Diurnal and Daily Variations in Growth Hormone and Growth Hormone Stimulation Test in Male Cynomolgus Monkeys.In Vivo2026 Jan-Feb

Sources

This is general research information, not medical advice. Check with a clinician before using any compound.

Preptide Pro is a tracking tool, not medical advice. Talk to a clinician about any treatment.